Gliosarcoma [clinicaltrials_resource:6e8fbba378d125f013a33bbf69e4fa94]
Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas [clinicaltrials:NCT00031083]Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols [clinicaltrials:NCT00035373]Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) [clinicaltrials:NCT00087451]clinicaltrials:NCT00102648GW572016 to Treat Recurrent Malignant Brain Tumors [clinicaltrials:NCT00107003]131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma [clinicaltrials:NCT00114309]Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00165477]clinicaltrials:NCT00187486clinicaltrials:NCT00354913clinicaltrials:NCT00365222clinicaltrials:NCT00402116clinicaltrials:NCT00441142clinicaltrials:NCT00525525clinicaltrials:NCT00597402clinicaltrials:NCT00609999clinicaltrials:NCT00610571clinicaltrials:NCT00611325clinicaltrials:NCT00612339clinicaltrials:NCT00612430clinicaltrials:NCT00612638clinicaltrials:NCT00612651clinicaltrials:NCT00612989clinicaltrials:NCT00613028clinicaltrials:NCT00613054clinicaltrials:NCT00613132clinicaltrials:NCT00613223clinicaltrials:NCT00615927clinicaltrials:NCT00657267clinicaltrials:NCT00667394clinicaltrials:NCT00671970clinicaltrials:NCT00672243clinicaltrials:NCT00734526clinicaltrials:NCT00734682clinicaltrials:NCT00734864clinicaltrials:NCT00735436Valproic Acid and Radiation Followed by Maintenance Valproic Acid and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma [clinicaltrials:NCT00879437]clinicaltrials:NCT00884416clinicaltrials:NCT00936052Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma [clinicaltrials:NCT00960492]clinicaltrials:NCT00979017
condition [clinicaltrials_vocabulary:condition]
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor [clinicaltrials:NCT00001148]clinicaltrials:NCT00002463Combination Chemotherapy for Patients With Brain Cancer [clinicaltrials:NCT00002814]Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma [clinicaltrials:NCT00003468]Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma [clinicaltrials:NCT00003470]Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma [clinicaltrials:NCT00003471]Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma [clinicaltrials:NCT00003537]clinicaltrials:NCT00003621Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse [clinicaltrials:NCT00003775]IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma [clinicaltrials:NCT00003842]Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma [clinicaltrials:NCT00004017]Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00004078]clinicaltrials:NCT00004146clinicaltrials:NCT00004259Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00004262]Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [clinicaltrials:NCT00004688]SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy [clinicaltrials:NCT00004868]Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma [clinicaltrials:NCT00005084]Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00005856]Bortezomib in Treating Patients With Recurrent Glioma [clinicaltrials:NCT00006773]Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [clinicaltrials:NCT00008008]Natural History of Patients With Brain and Spinal Cord Tumors [clinicaltrials:NCT00009035]Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [clinicaltrials:NCT00012181]Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00014170]CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00016328]clinicaltrials:NCT00017147Stereotactic Radiosurgery in Treating Patients With Brain Tumors [clinicaltrials:NCT00019578]Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients [clinicaltrials:NCT00024557]Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma [clinicaltrials:NCT00024570]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas [clinicaltrials:NCT00031083]Genetic Analysis of Brain Tumors [clinicaltrials:NCT00031538]Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols [clinicaltrials:NCT00035373]Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors [clinicaltrials:NCT00039494]Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00041587]clinicaltrials:NCT00042991Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [clinicaltrials:NCT00045110]Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [clinicaltrials:NCT00045565]A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas [clinicaltrials:NCT00045708]clinicaltrials:NCT00045968
condition browse [clinicaltrials_vocabulary:condition-browse]
Detecting Malignant Brain Tumor Cells in the Bloodstream During Surgery to Remove the Tumor [clinicaltrials:NCT00001148]clinicaltrials:NCT00002463Combination Chemotherapy for Patients With Brain Cancer [clinicaltrials:NCT00002814]Antineoplaston Therapy in Treating Children With Low-Grade Astrocytoma [clinicaltrials:NCT00003468]Antineoplaston Therapy in Treating Patients With Anaplastic Astrocytoma [clinicaltrials:NCT00003470]Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma [clinicaltrials:NCT00003471]Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma [clinicaltrials:NCT00003537]clinicaltrials:NCT00003621Leflunomide in Treating Patients With Anaplastic Astrocytoma in First Relapse [clinicaltrials:NCT00003775]IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma [clinicaltrials:NCT00003842]Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma [clinicaltrials:NCT00004017]Irinotecan in Treating Children With Refractory Solid Tumors [clinicaltrials:NCT00004078]clinicaltrials:NCT00004146clinicaltrials:NCT00004259Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00004262]Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms [clinicaltrials:NCT00004688]SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy [clinicaltrials:NCT00004868]Magnetic Resonance Imaging in Treating Children With Progressive Low-Grade Astrocytoma [clinicaltrials:NCT00005084]Oxaliplatin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00005856]Bortezomib in Treating Patients With Recurrent Glioma [clinicaltrials:NCT00006773]Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma [clinicaltrials:NCT00008008]Natural History of Patients With Brain and Spinal Cord Tumors [clinicaltrials:NCT00009035]Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas [clinicaltrials:NCT00012181]Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00014170]CCI-779 in Treating Patients With Recurrent Glioblastoma Multiforme [clinicaltrials:NCT00016328]clinicaltrials:NCT00017147Stereotactic Radiosurgery in Treating Patients With Brain Tumors [clinicaltrials:NCT00019578]Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients [clinicaltrials:NCT00024557]Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma [clinicaltrials:NCT00024570]Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction [clinicaltrials:NCT00030498]Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas [clinicaltrials:NCT00031083]Genetic Analysis of Brain Tumors [clinicaltrials:NCT00031538]Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols [clinicaltrials:NCT00035373]Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors [clinicaltrials:NCT00039494]Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma [clinicaltrials:NCT00041587]clinicaltrials:NCT00042991Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [clinicaltrials:NCT00045110]Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [clinicaltrials:NCT00045565]A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas [clinicaltrials:NCT00045708]clinicaltrials:NCT00045968
condition mesh [clinicaltrials_vocabulary:condition-mesh]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT00085540 [clinicaltrials_resource:758688ea2976b637472c0ec68e514e3f]eligibility for clinicaltrials:NCT00990652 [clinicaltrials_resource:abbefc2fbe45534659ba5cb7ea876e18]eligibility for clinicaltrials:NCT01236560 [clinicaltrials_resource:ac10ff281ad7e2db3242476e33dbb3ac]eligibility for clinicaltrials:NCT00679354 [clinicaltrials_resource:b06ea8f3c76ee250961f04e4dfdfa2df]eligibility for clinicaltrials:NCT00070525 [clinicaltrials_resource:bbc57e24ec459e18f6e64dc2c331a766]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Gliosarcoma [clinicaltrials_resource:6e8fbba378d125f013a33bbf69e4fa94]
Bio2RDF identifier
6e8fbba378d125f013a33bbf69e4fa94
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6e8fbba378d125f013a33bbf69e4fa94
identifier
clinicaltrials_resource:6e8fbba378d125f013a33bbf69e4fa94
title
Gliosarcoma
@en
type
label
Gliosarcoma [clinicaltrials_resource:6e8fbba378d125f013a33bbf69e4fa94]
@en
Gliosarcoma